M. Kazma
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 8
-
- Urinary Tract Infections Management 4
- Co-authors
- Yehuda Carmeli (10 shared papers)T. Kotlovsky (4 shared papers)Vered Schechner (2 shared papers)Shiri Navon‐Venezia (2 shared papers)David A. Schwartz (2 shared papers)Mitchell J. Schwaber (3 shared papers)Hagit Mishali (1 shared paper)Christine Lammens (7 shared papers)
In The Last Decade
M. Kazma
11 papers receiving 470 citations
Peers
Comparison fields: 5 of 46
- Molecular Medicine 364
- Applied Microbiology and Biotechnology 69
- Endocrinology 127
- Clinical Biochemistry 57
- Pollution 44
Countries citing papers authored by M. Kazma
This map shows the geographic impact of M. Kazma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kazma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kazma more than expected).
Fields of papers citing papers by M. Kazma
This network shows the impact of papers produced by M. Kazma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kazma. The network helps show where M. Kazma may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Kazma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 142 | |
| 2 | 2012 | 67 | |
| 3 | 2011 | 59 | |
| 4 | 2012 | 55 | |
| 5 | 2013 | 43 | |
| 6 | 2019 | 39 | |
| 7 | 2014 | 24 | |
| 8 | 2014 | 21 | |
| 9 | 2012 | 17 | |
| 10 | 2011 | 11 | |
| 11 | 2012 | 8 |
About M. Kazma
M. Kazma is a scholar working on Molecular Medicine, Epidemiology, Endocrinology, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 11 papers that have together received 486 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (8 papers), Urinary Tract Infections Management (4 papers), Enterobacteriaceae and Cronobacter Research (4 papers), Streptococcal Infections and Treatments (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Antibiotic Use and Resistance (1 paper), Clostridium difficile and Clostridium perfringens research (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Molecular Medicine (364 citations), Applied Microbiology and Biotechnology (69 citations), Endocrinology (127 citations), Clinical Biochemistry (57 citations) and Pollution (44 citations). M. Kazma has collaborated with scholars based in Israel, Belgium and Poland. Frequent co-authors include Yehuda Carmeli, T. Kotlovsky, Vered Schechner, Shiri Navon‐Venezia, David A. Schwartz, Mitchell J. Schwaber, Hagit Mishali, Christine Lammens, Herman Goossens and Yaffa Lerman. Their work appears in journals such as Clinical Microbiology and Infection, Antimicrobial Agents and Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases, Infection Control and Hospital Epidemiology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.